IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 316 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.96 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $10,000 | +11.1% | 157 | +36.5% | 0.00% | 0.0% |
Q1 2019 | $9,000 | +50.0% | 115 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $6,000 | +50.0% | 115 | +59.7% | 0.00% | +200.0% |
Q3 2018 | $4,000 | +33.3% | 72 | +16.1% | 0.00% | 0.0% |
Q2 2018 | $3,000 | +200.0% | 62 | +121.4% | 0.00% | – |
Q1 2018 | $1,000 | 0.0% | 28 | 0.0% | 0.00% | – |
Q4 2017 | $1,000 | 0.0% | 28 | 0.0% | 0.00% | – |
Q3 2017 | $1,000 | 0.0% | 28 | 0.0% | 0.00% | – |
Q2 2017 | $1,000 | 0.0% | 28 | 0.0% | 0.00% | – |
Q1 2017 | $1,000 | 0.0% | 28 | 0.0% | 0.00% | – |
Q4 2016 | $1,000 | 0.0% | 28 | 0.0% | 0.00% | -100.0% |
Q3 2016 | $1,000 | 0.0% | 28 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $1,000 | -66.7% | 28 | -58.2% | 0.00% | -66.7% |
Q1 2016 | $3,000 | +50.0% | 67 | +139.3% | 0.00% | +50.0% |
Q4 2015 | $2,000 | – | 28 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sicart Associates LLC | 367,360 | $14,768,000 | 10.67% |
BB BIOTECH AG | 7,461,295 | $299,944,000 | 9.81% |
TANAKA CAPITAL MANAGEMENT INC | 83,399 | $3,353,000 | 7.39% |
DOWLING & YAHNKE LLC | 675,843 | $27,169,000 | 2.89% |
Opus Point Partners Management, LLC | 78,900 | $3,172,000 | 2.35% |
Motley Fool Asset Management LLC | 259,000 | $10,412,000 | 2.25% |
ARK Investment Management | 127,563 | $5,128,000 | 1.48% |
Motley Fool Wealth Management, LLC | 325,965 | $13,104,000 | 1.26% |
PINNACLE ASSOCIATES LTD | 1,514,710 | $60,891,000 | 1.16% |
Bellevue Group AG | 205,253 | $8,251,000 | 1.10% |